Allergan Receives FDA Warning Letter re Latisse Eyelash Thickener

The Food and Drug Administration sent a warning letter to Allergan concerning its eyelash thickener Latisse. In the letter dated Sept. 10 and posted to the FDA Web site on Sept. 17, the FDA states that the Latisse Web site does not include adequate warnings for possible side effects from using Latisse, and asks the company to comply with its request to modify the site. Allergan must reply to the letter by Sept. 24.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: